Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-12-000285
Filing Date
2012-12-14
Accepted
2012-12-14 15:46:57
Documents
11
Period of Report
2012-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq3oct3112w01.htm 10-Q 237120
8 EXHIBIT 31.1 neurokinesection302certceoq3.htm EX-31 7738
9 EXHIBIT 31.2 neurokinesection302certcfoq3.htm EX-31 7822
10 EXHIBIT 32.1 neurokinesection906certceoq3.htm EX-32 5674
11 EXHIBIT 32.2 neurokinesection906certcfoq3.htm EX-32 5664
  Complete submission text file 0001511164-12-000285.txt   2250089

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT neukf-20121031.xml EX-101.INS 296195
3 XBRL TAXONOMY EXTENSION SCHEMA neukf-20121031.xsd EX-101.SCH 34892
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20121031_cal.xml EX-101.CAL 17974
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20121031_def.xml EX-101.DEF 118379
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20121031_lab.xml EX-101.LAB 130888
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20121031_pre.xml EX-101.PRE 116317
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 121265548
SIC: 2834 Pharmaceutical Preparations